GENERAL INTEREST-Notice of Information Regarding the "Announcement of Antimicrobial Resistance Rapid, Point-of-Need Diagnostic Test Challenge Competition"; August 3, 2018

 

Notice Number: NOT-OD-17-063

 

Key Dates
Release Date: May 5, 2017

 

Related Announcements
NOT-OD-16-137

 

Issued by
National Institutes of Health (NIH)
Biomedical Advances Research and Development Authority (BARDA)

 

Purpose

The purpose of this Notice is to inform the community about updates and clarifications of several components of the Challenge competition posted within the Federal Register  including:

 

Current language:
Eligibility to Win:  The Solver shall submit a letter of intent outlining the proposed in vitro diagnostic assay/assay system and its intended use.

 

Modified language:
The letter of intent must be submitted by August 3, 2018, at 11:59 p.m. ET, for all “Solvers” planning to submit for the Step 2 (Delivery of Prototype and Analytical Data) stage of the competition.  The letter of intent must be submitted on http://www.cccinnovationcenter.com/challenges/antimicrobial-resistance-diagnostic-challenge/

 

Current language:
The Technical Evaluation Panel will use the following 8 criteria and rating scales for evaluating proposed Step 2 submissions: a) innovation; b) clinical significance; c) diagnostic performance; d) feasibility; e) setting and ease of use; f) sample matrix; g) throughput; and h) data content.  

 

Modified language:
The Technical Evaluation Panel will use the following 4 criteria for evaluating the Step 2 submissions including: a) innovation; b) clinical significance; c) diagnostic performance and feasibility; and d) sample matrix/setting and ease of use/throughput.

 

Link to Full Announcement
https://grants.nih.gov/grants/guide/notice-files/NOT-OD-17-063.html